Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PASG
#4481
Passage Bio, Inc. Common Stock
10.860
0
USD
+0.46%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+0.46%
Mudança mensal
+44.03%
Mudança em 6 meses
+22.85%
Mudança anual
+22.85%
Fechamento anterior
10.810
0
Abrir
10.860
0
Bid
Ask
Mínimo
10.860
0
High
10.860
0
Volume
4
Mercados
Ações
Cuidados de saúde
PASG
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.69 M
2.71 M
2.73 M
2.78 M
3.11 M
3.21 M
—
Valuation ratios
Enterprise value
1.24 B
215.79 M
53.88 M
28.39 M
-2.33 M
-8.45 M
-109.29 M
Price to earnings ratio
—
-1.82
-0.65
-0.48
-0.53
-0.82
-2.15
Price to sales ratio
—
—
—
-106.54
34.71
25.52
76.94
Price to cash flow ratio
—
-2.67
-0.75
-0.63
-0.71
-1.19
-3.13
Price to book ratio
—
1.06
0.44
0.44
0.56
2
2.33
Enterprise value to EBITDA ratio
—
—
—
-0.64
0.09
0.35
4.4
Profitability ratios
Return on assets %
-0.34
-0.52
-0.56
-0.68
-0.63
-0.73
-0.61
Return on equity %
-0.37
-0.58
-0.68
-0.92
-1.06
-2.43
-1.52
Return on invested capital %
-1 311.26
-1 527.49
-819.29
-737.43
-492.97
—
—
Gross margin %
—
—
—
100
100
100
400
Operating margin %
—
—
—
23.41 K
-7 132.73
-3 360.33
-13.45 K
EBITDA margin %
—
—
—
9 541.04
-2 649.75
-1 624.06
-6 498.52
Net margin %
—
—
—
22.04 K
-6 562.01
-3 103.07
-12.42 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.98
11.02
10.74
7.22
4.07
2.07
11.36
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
-0
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-47.57
-43.44
-28.59
-15.88
-9.93
-10.03
EBIT per share
—
—
—
-17.5
-9.68
-7.74
-7.79
EBITDA per share
—
—
—
-16.14
-8.66
-7.51
-7.56
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
118.39
69.67
41.76
25.41
14.59
69.78
Net current asset value per share
—
121.88
72.4
43.1
26.1
15.05
73.09
Tangible book value per share
—
119.47
73.99
40.66
20.28
5.91
42.81
Working capital per share
—
110.82
65.66
37.13
19.68
7.78
46.83
Book value per share
—
119.47
73.99
40.66
20.28
5.91
42.81
Notícias
Baird inicia cobertura de ações da Passage Bio com classificação de desempenho superior
Oppenheimer inicia cobertura de Passage Bio com classificação de desempenho superior
Lucid Capital Markets inicia cobertura da Passage Bio com recomendação de compra
Lucid Capital Markets initiates Passage Bio stock with Buy rating
Monday’s Insider Moves: Key Buys and Sells in US Stocks Revealed
Lynx1 Capital compra ações da Passage Bio (PASG) no valor de US$ 223.734
Lynx1 Capital buys Passage Bio (PASG) shares worth $223,734
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
Guggenheim lowers Passage Bio stock price target to $10 from $40
Canaccord Genuity lowers Passage Bio stock price target to $67 from $260
Lynx1 capital buys Passage Bio (PASG) shares worth $733,825